These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25776533)

  • 1. Verifying the markers of ovarian cancer using RNA-seq data.
    Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
    Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly informative marker sets consisting of genes with low individual degree of differential expression.
    Galatenko VV; Shkurnikov MY; Samatov TR; Galatenko AV; Mityakina IA; Kaprin AD; Schumacher U; Tonevitsky AG
    Sci Rep; 2015 Oct; 5():14967. PubMed ID: 26446398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA sequencing (RNA-Seq) and its application in ovarian cancer.
    Wang J; Dean DC; Hornicek FJ; Shi H; Duan Z
    Gynecol Oncol; 2019 Jan; 152(1):194-201. PubMed ID: 30297273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.
    Zhang T; Xu J; Deng S; Zhou F; Li J; Zhang L; Li L; Wang QE; Li F
    PLoS One; 2018; 13(5):e0196351. PubMed ID: 29723215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
    Barrett CL; DeBoever C; Jepsen K; Saenz CC; Carson DA; Frazer KA
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3050-7. PubMed ID: 26015570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
    Xu G; Zhang M; Zhu H; Xu J
    Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Specific Cell Subpopulations and Marker Genes in Ovarian Cancer Using Single-Cell RNA Sequencing.
    Li Y; Wang J; Wang F; Gao C; Cao Y; Wang J
    Biomed Res Int; 2021; 2021():1005793. PubMed ID: 34660776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
    Vathipadiekal V; Wang V; Wei W; Waldron L; Drapkin R; Gillette M; Skates S; Birrer M
    Clin Cancer Res; 2015 Nov; 21(21):4960-9. PubMed ID: 25944803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
    Reinartz S; Finkernagel F; Adhikary T; Rohnalter V; Schumann T; Schober Y; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
    Genome Biol; 2016 May; 17(1):108. PubMed ID: 27215396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep transcriptome profiling of ovarian cancer cells using next-generation sequencing approach.
    Li L; Liu J; Yu W; Lou X; Huang B; Lin B
    Methods Mol Biol; 2013; 1049():139-69. PubMed ID: 23913215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
    Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles.
    De Smet F; Pochet NL; De Moor BL; Van Gorp T; Timmerman D; Vergote IB; Hartmann LC; Damokosh AI; Hoersch S
    Clin Cancer Res; 2005 Nov; 11(21):7958-9; author reply 7959. PubMed ID: 16278422
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.
    Rangel LB; Sherman-Baust CA; Wernyj RP; Schwartz DR; Cho KR; Morin PJ
    Oncogene; 2003 Oct; 22(46):7225-32. PubMed ID: 14562052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer.
    Fonville NC; Vaksman Z; McIver LJ; Garner HR
    Oncotarget; 2015 May; 6(13):11407-20. PubMed ID: 25779658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer.
    Gov E; Arga KY
    Sci Rep; 2017 Jul; 7(1):4996. PubMed ID: 28694494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
    Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.